MOTS-c vs 5-Amino-1MQ: Mitochondrial Research Comparison
Compare MOTS-c (mitochondrial-derived peptide) and 5-Amino-1MQ (NNMT inhibitor) in metabolic and mitochondrial research models.
MOTS-c vs 5-Amino-1MQ: Research Comparison
Both MOTS-c and 5-Amino-1MQ are studied in mitochondrial and adipose research, but they operate at completely different layers of biology. MOTS-c is a peptide that acts as a retrograde mitochondrial signal; 5-Amino-1MQ is a small molecule that protects the NAD+ pool by inhibiting a methyltransferase.
Mechanism of Action
MOTS-c is a mitochondrial-derived peptide (MDP). MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. It is studied as a signaling molecule modulating AMPK activation, insulin sensitivity, and metabolic homeostasis under stress.
5-Amino-1MQ is a small-molecule NNMT inhibitor. 5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), preserving the NAD+ precursor pool and increasing intracellular SAM availability. Research focuses on adipocyte metabolism and methyl-group economics.
Technical Comparison
| Parameter | MOTS-c | 5-Amino-1MQ | |---|---|---| | Class | mitochondrial-derived peptide (MDP) | small-molecule NNMT inhibitor | | Mechanism | MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial 12S rRNA gene. | 5-Amino-1MQ inhibits nicotinamide N-methyltransferase (NNMT), preserving the NAD+ precursor pool and increasing intracellular SAM availability. | | Half-life (research models) | Short circulating half-life; intracellular effects persist longer | Estimated 6β8 hours in research models | | Typical research dosing | 5β10 mg subcutaneous, intermittent | 100β150 mg oral, daily |
Comparative Findings
MOTS-c research has emphasized whole-body metabolic effects: improved glucose disposal, exercise capacity in aged animal models, and resistance to diet-induced obesity. 5-Amino-1MQ research has focused more narrowly on adipocyte biology, showing reduced adipogenesis and improved white-adipose mitochondrial function in published studies.
When Researchers Choose MOTS-c
Researchers select MOTS-c when studying mitochondrial-to-nuclear signaling, exercise mimetic pathways, or whole-organism metabolic stress responses.
When Researchers Choose 5-Amino-1MQ
Researchers select 5-Amino-1MQ when investigating NAD+ pool dynamics, NNMT-driven adipose pathology, or oral small-molecule alternatives to peptide injection.
Combination Research
Combination research is sparse but mechanistically rational: MOTS-c addresses mitochondrial signaling while 5-Amino-1MQ supports the NAD+/methyl economy that MOTS-c downstream pathways depend on.
Frequently Asked Questions
Are they interchangeable in metabolic research?
No. They operate at different levels β MOTS-c is a signaling peptide, 5-Amino-1MQ is an enzyme inhibitor. They are complementary rather than substitutable.
Which is more stable for long-term storage?
5-Amino-1MQ as a small molecule is more chemically stable than the MOTS-c peptide, which requires reconstitution and cold-chain handling.
Research-Use Disclosure
All content is provided strictly for laboratory research purposes. Compounds discussed are not for human or veterinary consumption. MOTS-c and 5-Amino-1MQ are research chemicals and have not been approved by the FDA for any therapeutic indication.
Related Research Materials
Parent Research Hubs
Related Research Articles
Retatrutide vs Semaglutide β Research Comparison
Side-by-side research comparison of retatrutide (GLP-1/GIP/glucagon triple agonist) and semaglutide (GLP-1 mono-agonist) β mechanism, pharmacokinetics, and metabolic-research literature.
Retatrutide vs Tirzepatide β Research Comparison
Triple agonist (retatrutide) vs dual agonist (tirzepatide) β side-by-side research comparison of receptor targets, pharmacokinetics, and published metabolic data.
HGH vs Tesamorelin β Research Comparison
Recombinant HGH (somatropin) vs Tesamorelin (GHRH analog) β side-by-side comparison of mechanism, IGF-1 induction, and visceral-adiposity research literature.